Pharmaceutical Technology
July 02, 2009
Issue PDF
33
7
Down the Track: Different Speeds with Multiple APIs
July 02, 2009
Special Section: Bioprocessing 2009
33
7
The author provides a review of PAT and tools such as near infrared analysis that may facilitate the use of PAT in the biopharmaceutical sector.
July 02, 2009
Outsourcing Outlook
33
7
A joint biopharmaceutical manufacturing facility in India by Kenwell and Boehringer Ingelheim ushers in new era.
July 02, 2009
Special Report
33
7
Formulators and manufacturers have many options for modifying release profiles in multiple-API products.
July 02, 2009
Special Section: Bioprocessing 2009
33
7
This case study describes the implementation of process analytical technology on the cultivation process step of a whole-cell vaccine against whooping cough disease.
July 02, 2009
Online Exclusives
33
7
Pan coating has been the preferred method of coating tablets for more than 20 years, but core coating is becoming more popular.
July 02, 2009
Washington Report
33
7
REMS to improve the safe use of opioids may lead to controls on other high-risk medicines.
July 02, 2009
PharmTech Talk
33
7
The regulators are doing it. But industry's fear of sharing information may leave them behind.
July 02, 2009
Special Section: Bioprocessing 2009
33
7
Dramatic increases in yields from cell lines and the increasing popularity of single-use technologies will change the way we look at future bioprocessing facilities and process designs.
July 02, 2009
Special Section: Bioprocessing 2009
33
7
A Pharmaceutical Technology report looks at trends in biopharmaceutical manufacturing. This article contains bonus online-exclusive material.
July 02, 2009
In the Spotlight
33
7
Editors' Picks of Pharmaceutical Science & Technology Innovations
July 02, 2009
Peer-Reviewed Research
33
7
The authors modified gellan gum using microwave technology and showed it can be used as an excipient in tablet formulations.
July 02, 2009
Online Exclusives
33
7
The authors review various oral drug delivery systems that have been explored to increase patient compliance for insulin.
July 02, 2009
Viewpoint
33
7
While regulators begin to address nano-based drugs, industry should get its risk data ready.
July 02, 2009
Agent-In-Place
33
7
Some GMP agents seem to find a way to squander time, money, and common sense.
July 02, 2009
Ingredients Insider
33
7
High-potency manufacturing of active pharmaceutical ingredients is a growing and specialized capability.
July 02, 2009
Inside USP
33
7
Traditional Chinese Medicine is widely used, but questions persist regarding its regulatory status.
July 02, 2009
Special Section: Bioprocessing 2009
33
7
A look at the true cost-drivers of cell-culture production.
July 02, 2009
Online Exclusives
33
7
Developers of low-dose drugs in solid oral dosage forms will find theoretical considerations and practical advice in a new book.
July 02, 2009
Peer-Reviewed Research
33
7
The authors discuss the theory of ion mobility spectrometry, its benefit over HPLC analysis in cleaning verification, and the experimental considerations for method validation and validation.
July 02, 2009
Special Section: Bioprocessing 2009
33
7
The authors describe a proprietary process for producing a stable, topical interferon alpha-2b formulation that can deliver large drug molecules into the skin or mucosa.
July 02, 2009
Special Section: Bioprocessing 2009
33
7
Large-scale manufacturing of human stem cells for therapeutic use is a leap in technology and science for the current biotechnology industry.
July 02, 2009
Special Section: Bioprocessing 2009
33
7
The authors discuss how strategic outsourcing to contract manufacturing organizations that have technical and regulatory expertise can add further value during vaccine development.
June 11, 2009
News
33
7
Patent infringement claims and a lack of clear global trade distribution routes may be unraveling the country's generic-drug export industry.